Seroprevalence of IgG antibodies against Bordetella pertussis in different age groups in Tehran, Iran

Iranian Journal of Pathology

Volumn 7, Issue 3, 2012, Pages 171-176

  Eslamifar, Ali ^a   Ramezani, Amitis ^a   Banifazl, Mohammad ^b   Khadem Sadegh, Akbar ^a   Aghakhani, Arezoo ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b Iranian Society for Support of Patients with Infectious Diseases   (Iran)

Author keywords

Bordetella pertussis; Iran; Seroepidemiology

Indexed keywords

EID: 84863880308     PISSN: 17355303     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Senzilet LD, Halperin SA, Spika JS, Alagaratnam M, Morris A, Smith B. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis 2001; 32:1691-7.
2. Wright SW. Pertussis infection in adults. South Med J 1998; 91:702-8.
3. Cherry JD. The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study. Curr Probl Pediatr 1984; 14:1-78.
4. Cherry JD, Brunnell PA, Golden GS, Karen DT. Report of the Task Force on pertussis and pertussis immunization. Pediatrics 1988; 81(Suppl.):939-84.
5. Socan M, Prosenc K, Vegnuti M. Seroprevalence of IgG antibodies to pertussis toxin in the Slovene population. Wien Klin Wochenschr 2006; 118(11-12):336-40.
6. Healy CM, Munoz FM, Rench MA, Halasa NB, Edwards KM, Baker CJ. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J Infect Dis 2004; 190:335-340.
7. Zarei S, Jeddi-Tehrani M, Akhondi MM, Zeraati H, Pourheidari F, Ostadkarampour M, et al. Primary immunization with a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian infants: an analysis of antibody response. Iran J Allergy Asthma Immunol 2009; 8(2):85-93.
8. Movahedi M, Haghdoost AA, Pournik O, Hajarizadeh B, Fallah MS. Temporal variations of health indicators in Iran comparing with other Eastern Mediterranean Region countries in the last two decades. J Public Health 2008; 30(4):499-504
9. Zahraei SM, Doosti F. Distribution of pertussis in Iran in 2007. The 17th Iranian congress on Infectious diseases and tropical medicine. Tehran, Iran. 2008. p. 129.
10. Ward JI, Cherry JD, Chang SJ, Partridge S, Lee H, Treanor J, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005; 353:1555-63.
11. Broder KR, Cortese MM, Iskander JK, Kretsinger K, Slade BA, Brown KH, et al. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55(RR-3):1-34.
12. Chan SH, Tan PT, Han HH, Bock HL. Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine as a single-dose booster in Singaporean adults. Singapore Med J 2006; 47:286-90.
13. Wharton M. Prevention of pertussis among adolescents by vaccination: taking action on what we know and acknowledging what we do not know. Clin Infect Dis 2004; 39:29-30.
14. Campins-Marti M, Cheng HK, Forsyth K, Guiso N, Halperin S, Huang LM, et al. Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration. Vaccine 2001; 20:641-6.
15. von Konig CH, Halperin S, Riffelmann M, Guiso N. Pertussis of adults and infants. Lancet Infect Dis 2002; 2:744-50.
16. Diez-Domingo J, Ballester A, Baldo JM, Planelles MV, Villarroya JV, Alvarez T, et al. Incidence of pertussis in persons < or =15 years of age in Valencia, Spain: seroprevalence of antibodies to pertussis toxin (PT) in children, adolescents, and adults. J Infect. 2004;49(3):242-7.
17. Garcia-Corbeira P, Dal-Re R, Aguilar L, Garcia-de-Lomas J. Seroepidemiology of Bordetella pertussis infections in the Spanish population: a cross-sectional study. Vaccine 2000;18(21):2173-6.
18. Wilder-Smith A, Ng S, Earnest A. Seroepidemiology of pertussis in the adult population of Singapore. Ann Acad Med Singapore 2006;35(11):780-2.
19. Strebel P, Nordin J, Edwards K, Hunt J, Besser J, Burns S, et al. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996. J Infect Dis 2001; 183:1353-9.
20. Mink CM, Cherry JD, Christenson P, Lewis K, Pineda E, Shlian D, et al. A search for Bordetella pertussis infection in university students. Clin Infect Dis 1992; 14:464-471.
21. Keitel WA, Edwards KM. Pertussis in adolescents and adults: time to reimmunize? Semin Respir Infect 1995; 10:51-7.
22. Purdy KW, Hay JW, Botteman MF, Ward JI. Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a cost-benefit analysis. Clin Infect Dis 2004; 39:20-8.
23. Greco D, Salmaso S, Mastrantonio P, Giuliano M, Tozzi AE, Anemona A, et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med 1996; 334:341-348.
24. Polyzou A, Pournaras S, Dafni U, Sofianou D, Christeli E, Patrinos S, et al. Sero epidemiology of Bordetella pertussis immune responses in a healthy population in northern Greece. J Clin Lab Anal 2004; 18(3):211-4.
25. Zarei S, Jeddi-Tehrani M, Akhondi MM, Zeraati H, Kheirkhah T, Ghazanfari M, et al. Immunogenicity of a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian preschool children. Iran J Immunol 2007; 4(2):101-9.
26. Sherkat R, Salehy H, Yazdani R. The assessment of the Bordetella pertussis in adults with cough ≥ 6 weeks. The 14th Iranian Congress on Infectious Diseases and Tropical Medicine. 2005. p. 216.
27. Hashemi SH, Ranjbar M, Hajilooi M, Seif-Rabiei MA, Bolandi M, Moghimi J. Seroprevalence of Immunoglobulin G antibodies against pertussis toxin among asymptomatic medical students in the west of Iran: a cross sectional study. BMC Infect Dis 2009; 9:58.